JAMIE TAYLOR: Open Payments
NPI 1134732589 · LIZELLA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 33 payments from 15 companies in 2025. Trend: 2023 $233 · 2024 $627 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Corcept Therapeutics | 4 | $81 |
| Novo Nordisk Inc | 4 | $74 |
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $31 |
Products named: Korlym, AIRSUPRA, VRAYLAR, Ozempic, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE, REXULTI.
Industry payments across GA — which companies pay providers there.
